Clinical Trial Update: A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial update on bemarituzumab in combination with other anti-cancer therapies for previously untreated advanced gastric and gastroesoph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Bemarituzumab (bemarituzumab)

Snippet

Sponsor: Amgen | Conditions: Gastric Cancer, Gastroesophageal Junction Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING